Search

Your search keyword '"Brueggen, Marie-Charlotte"' showing total 19 results
Start Over Author "Brueggen, Marie-Charlotte"
19 results on '"Brueggen, Marie-Charlotte"'

2. The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions

Author

Yazici, Duygu, Ogulur, Ismail, Pat, Yagiz, Babayev, Huseyn, Barletta, Elena, Ardicli, Sena, Bel imam, Manal, Huang, Mengting, Koch, Jana, Li, Manru, Maurer, Debbie, Radzikowska, Urszula, Satitsuksanoa, Pattraporn, Schneider, Stephan R., Sun, Na, Traidl, Stephan, Wallimann, Alexandra, Wawrocki, Sebastian, Zhakparov, Damir, Fehr, Danielle, Ziadlou, Reihane, Mitamura, Yasutaka, Brüggen, Marie-Charlotte, van de Veen, Willem, Sokolowska, Milena, Baerenfaller, Katja, Nadeau, Kari, Akdis, Mubeccel, and Akdis, Cezmi A.

Published
2023
Full Text
View/download PDF

3. Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN

Author

Hama, Natsumi, Sunaga, Yuma, Ochiai, Hirotaka, Kokaze, Akatsuki, Watanabe, Hideaki, Kurosawa, Michiko, Azukizawa, Hiroaki, Asada, Hideo, Watanabe, Yuko, Yamaguchi, Yukie, Aihara, Michiko, Mizukawa, Yoshiko, Ohyama, Manabu, Hashizume, Hideo, Nakajima, Saeko, Nomura, Takashi, Kabashima, Kenji, Tohyama, Mikiko, Hasegawa, Akito, Takahashi, Hayato, Mieno, Hiroki, Ueta, Mayumi, Sotozono, Chie, Niihara, Hiroyuki, Morita, Eishin, Brüggen, Marie-Charlotte, Feingold, Iris Motro, Jeschke, Marc G., Dodiuk-Gad, Roni P., Oppel, Eva Maria, French, Lars E., Chen, Wei-Ti, Chung, Wen-Hung, Chu, Chia-Yu, Kang, Hye-Ryun, Ingen-Housz-Oro, Saskia, Nakamura, Kazutoshi, Sueki, Hirohiko, and Abe, Riichiro

Published
2023
Full Text
View/download PDF

18. Advances and highlights in biomarkers of allergic diseases

Author

ÖĞÜLÜR, İSMAİL, Ogulur, Ismail, Pat, Yagiz, Ardicli, Ozge, Barletta, Elena, Cevhertas, Lacin, Fernandez-Santamaria, Ruben, Huang, Mengting, Imam, Manal Bel, Koch, Jana, Ma, Siyuan, Maurer, Debbie J., Mitamura, Yasutaka, Peng, Yaqi, Radzikowska, Urszula, Rinaldi, Arturo O., Rodriguez-Coira, Juan, Satitsuksanoa, Pattraporn, Schneider, Stephan R., Wallimann, Alexandra, Zhakparov, Damir, Ziadlou, Reihane, Brueggen, Marie-Charlotte, van de Veen, Willem, Sokolowska, Milena, Baerenfaller, Katja, Zhang, Luo, Akdis, Mubeccel, and Akdis, Cezmi A.

Subjects
allergic diseases, precision medicine, INDUCTION, biomarkers, COVID-19, PHENOTYPES, IMMUNOLOGY, MECHANISMS, SUBLINGUAL IMMUNOTHERAPY, CELLS, allergen immunotherapy, ASTHMA, TOLERANCE, ENDOTYPES
Abstract

During the past years, there has been a global outbreak of allergic diseases, presenting a considerable medical and socioeconomical burden. A large fraction of allergic diseases is characterized by a type 2 immune response involving Th2 cells, type 2 innate lymphoid cells, eosinophils, mast cells, and M2 macrophages. Biomarkers are valuable parameters for precision medicine as they provide information on the disease endotypes, clusters, precision diagnoses, identification of therapeutic targets, and monitoring of treatment efficacies. The availability of powerful omics technologies, together with integrated data analysis and network-based approaches can help the identification of clinically useful biomarkers. These biomarkers need to be accurately quantified using robust and reproducible methods, such as reliable and point-of-care systems. Ideally, samples should be collected using quick, cost-efficient and noninvasive methods. In recent years, a plethora of research has been directed toward finding novel biomarkers of allergic diseases. Promising biomarkers of type 2 allergic diseases include sputum eosinophils, serum periostin and exhaled nitric oxide. Several other biomarkers, such as pro-inflammatory mediators, miRNAs, eicosanoid molecules, epithelial barrier integrity, and microbiota changes are useful for diagnosis and monitoring of allergic diseases and can be quantified in serum, body fluids and exhaled air. Herein, we review recent studies on biomarkers for the diagnosis and treatment of asthma, chronic urticaria, atopic dermatitis, allergic rhinitis, chronic rhinosinusitis, food allergies, anaphylaxis, drug hypersensitivity and allergen immunotherapy. In addition, we discuss COVID-19 and allergic diseases within the perspective of biomarkers and recommendations on the management of allergic and asthmatic patients during the COVID-19 pandemic.

Published
2021

19. Dysregulation of the epithelial barrier by environmental and other exogenous factors

Author

ÖĞÜLÜR, İSMAİL, Mitamura, Yasutaka, Ogulur, Ismail, Pat, Yagiz, Rinaldi, Arturo O., Ardicli, Ozge, Cevhertas, Lacin, Brueggen, Marie-Charlotte, Traidl-Hoffmann, Claudia, Akdis, Mubeccel, and Akdis, Cezmi A.

Subjects
atopic dermatitis, LYMPHOID-CELLS, ANIONIC SURFACTANTS, sinusitis, type 2 immunity, asthma, allergy, ALLERGIC RHINITIS, rhinitis, RAMAN-SPECTROSCOPY, FILAGGRIN MUTATIONS, ELECTRICAL-IMPEDANCE SPECTROSCOPY, HUMAN SKIN, PULMONARY-DISEASE, ATOPIC-DERMATITIS, barrier dysfunction, EAACI GUIDELINES, epithelium
Abstract

The epithelial barrier hypothesis proposes that the exposure to various epithelial barrier-damaging agents linked to industrialization and urbanization underlies the increase in allergic diseases. The epithelial barrier constitutes the first line of physical, chemical, and immunological defense against environmental factors. Recent reports have shown that industrial products disrupt the epithelial barriers. Innate and adaptive immune responses play an important role in epithelial barrier damage. In addition, recent studies suggest that epithelial barrier dysfunction plays an essential role in the pathogenesis of the atopic march by allergen sensitization through the transcutaneous route. It is evident that external factors interact with the immune system, triggering a cascade of complex reactions that damage the epithelial barrier. Epigenetic and microbiome changes modulate the integrity of the epithelial barrier. Robust and simple measurements of the skin barrier dysfunction at the point-of-care are of significant value as a biomarker, as recently reported using electrical impedance spectroscopy to directly measure barrier defects. Understanding epithelial barrier dysfunction and its mechanism is key to developing novel strategies for the prevention and treatment of allergic diseases. The aim of this review is to summarize recent studies on the pathophysiological mechanisms triggered by environmental factors that contribute to the dysregulation of epithelial barrier function.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results